← ANALYSTS · TIPRANKS
Geoff Meacham · Citi
Hits
60%
292 of 485 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+15.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
26
Buy / hold / sell: 17 / 7 / 2
Upside of the analyst’s targets
+48.2%
Average over 26 current targets, to the last price
The market’s answer to the ratings
+2.5%
Day-0 move against SPY in the rating’s direction, average over 14 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks Oct 16 05:40 | NUVBIWMNuvation Bio · $1.7B | Reiterated | Buy | $12.00 | +169.7% | +1.2%next day −5.2% | ↗ |
| Oct 15on TipRanks Oct 16 05:25 | FTHFaeth Therapeutics · $517M | Reiterated | Buy | $55.00 | +192.6% | +2.7%next day −7.6% | ↗ |
| Oct 15on TipRanks Oct 16 05:20 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $74.00 | +85.5% | +2.3%next day −0.7% | |
| Oct 15on TipRanks 07:55 | ABOSIWMAcumen Pharmaceuticals · $126M | Reiterated | Buy | $5.00 | +195.9% | −4.6%next day +2.3% | ↗ |
| Oct 15on TipRanks 07:55 | VORIWMVor Biopharma · $1.1B | Reiterated | Buy | $50.00 | +177.3% | +2.9%next day −5.7% | ↗ |
| Oct 15on TipRanks 07:50 | KNSAIWMKiniksa Pharmaceuticals · $6.2B | Reiterated | Buy | $100 | +27.2% | +1.1%next day −0.6% | ↗ |
| Oct 15on TipRanks 07:50 | MANEIWMVeradermics, Incorporated · $4.8B | Reiterated | Buy | $160 | +47.0% | +1.1%next day −4.3% | ↗ |
| Oct 15on TipRanks 07:50 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $182 | +41.4% | −0.1%next day −4.6% | ↗ |
| Oct 15on TipRanks 07:45 | NAMSNewAmsterdam Pharma Company · $2.4B | Reiterated | Buy | $55.00 | +177.4% | +2.8%next day −2.7% | ↗ |
| Oct 15on TipRanks 07:45 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $150 | +43.2% | +0.9%next day −2.0% | ↗ |
| Oct 15on TipRanks 07:36 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $325 | +54.6% | +2.0%next day −0.8% | ↗ |
| Oct 15on TipRanks 07:30 | MRNAQQQSPYModerna · $94.4B | Reiterated | Sell | $80.00 | −63.3% | +4.2%next day −6.7% | ↗ |
| Oct 15on TipRanks 05:55 | AMLXIWMAmylyx Pharmaceuticals Inc · $3.4B | Reiterated | Buy | $32.00 → $39.00+21.9% | +48.1% | +2.0%next day −3.6% | ↗ |
| Oct 15on TipRanks 05:55 | NVAXIWMNovavax · $2.1B | Reiterated | Sell | $7.00 → $8.00+14.3% | −29.0% | +1.1%next day −11.1% | ↗ |
| Oct 13on TipRanks 10:50 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $125 | +42.5% | −7.1%next day +0.7% | ↗ |
| Oct 13on TipRanks 07:15 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $70.00 | +17.2% | −1.6%next day +5.7% | ↗ |
| Oct 12on TipRanks 08:01 | ABBVSPYAbbVie · $501B | Reiterated | Hold | $260 | −8.9% | +1.7%next day −2.4% | ↗ |
| Oct 12on TipRanks 07:50 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Buy | $165 | +5.6% | −0.4%next day −1.7% | ↗ |
| Oct 12on TipRanks 07:45 | RPRXRoyalty Pharma · $32.7B | Reiterated | Buy | $70.00 | +14.8% | +1.6%next day −2.1% | ↗ |
| Oct 12on TipRanks 07:45 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,600 | +27.3% | +0.3%next day −1.4% | ↗ |
| Oct 12on TipRanks 07:35 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | $215 | −7.6% | +1.7%next day −0.2% | ↗ |
| Oct 12on TipRanks 07:35 | AMGNQQQSPYAmgen · $235B | Reiterated | Hold | $405 | −6.4% | +0.7%next day −1.1% | ↗ |
| Oct 12on TipRanks 06:15 | PFESPYPfizer · $168B | Reiterated | Hold | $27.00 | −8.7% | +0.5%next day −0.1% | ↗ |
| Oct 12on TipRanks 06:15 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Hold | $740 | −6.4% | +2.2%next day −1.3% | ↗ |
| Oct 12on TipRanks 06:15 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $575 → $585+1.7% | +17.1% | −0.5%next day −4.3% | ↗ |
| Oct 12on TipRanks 05:55 | MRKSPYMerck & Company · $358B | Reiterated | Hold | $145 | −0.7% | 0.0%next day −2.4% | ↗ |
| Oct 9on TipRanks 10:15 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $70.00 | +17.2% | −1.4%next day −2.5% · 5 days +3.0% | ↗ |
| Oct 5on TipRanks 05:31 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $135 → $150+11.1% | +43.2% | +1.6%next day −4.1% · 5 days +1.6% | ↗ |
| Oct 2on TipRanks Oct 5 08:12 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Hold | $740 | −6.4% | −0.7%next day −1.9% · 5 days +0.4% | ↗ |
| Oct 2on TipRanks Oct 5 07:45 | PFESPYPfizer · $168B | Reiterated | Hold | $27.00 | −8.7% | −1.9%next day −2.1% · 5 days +0.6% | ↗ |
| Sep 30on TipRanks 06:15 | NUVBIWMNuvation Bio · $1.7B | Initiated | Buy | $12.00 | +169.7% | −0.2%next day −0.9% · 5 days −15.1% | ↗ |
| Sep 30on TipRanks 06:10 | JAZZJazz Pharmaceuticals · $13.9B | Initiated | Buy | $325 | +54.6% | −0.2%next day +0.5% · 5 days −2.1% | ↗ |
| Sep 30on TipRanks 05:15 | MRNAQQQSPYModerna · $94.4B | Downgrade | Sell | $60.00 → $80.00+33.3% | −63.3% | −5.1%next day −2.1% · 5 days +0.1% | ↗ |
| Sep 29on TipRanks 06:50 | MRKSPYMerck & Company · $358B | Reiterated | Hold | $125 | −14.4% | +0.6%next day −2.5% · 5 days −6.9% | ↗ |
| Sep 29on TipRanks 06:50 | ABBVSPYAbbVie · $501B | Reiterated | Hold | $260 | −8.9% | −0.9%next day −0.4% · 5 days −0.7% | ↗ |
| Sep 28on TipRanks 11:55 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Hold | $740 | −6.4% | −3.8%next day 0.0% · 5 days −4.6% | ↗ |
| Sep 23on TipRanks 06:50 | VRTXQQQSPYVertex Pharmaceuticals · $129B | Reiterated | Buy | $585 | +17.1% | +1.0%next day +1.3% · 5 days +1.9% | ↗ |
| Sep 23on TipRanks Sep 22 11:00 | AMGNQQQSPYAmgen · $235B | Reiterated | Hold | $405 | −6.4% | +4.4%next day −0.3% · 5 days +4.5% | ↗ |
| Sep 15on TipRanks 06:30 | MANEIWMVeradermics, Incorporated · $4.8B | Reiterated | Buy | $160 | +47.0% | +2.6%next day −1.0% · 5 days +11.4% | ↗ |
| Sep 15on TipRanks 06:20 | ABOSIWMAcumen Pharmaceuticals · $126M | Reiterated | Buy | $4.00 → $5.00+25.0% | +195.9% | +4.0%next day −9.2% · 5 days −10.7% | ↗ |
| Sep 14on TipRanks Sep 13 21:10 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $60.00 → $74.00+23.3% | +85.5% | −6.0%next day −3.1% · 5 days −9.0% | ↗ |
| Sep 9on TipRanks Sep 10 06:10 | VORIWMVor Biopharma · $1.1B | Reiterated | Buy | $50.00 | +177.3% | −7.0%next day −3.3% · 5 days −4.4% | ↗ |
| Sep 9on TipRanks Sep 10 06:10 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $175 → $182+4.0% | +41.4% | −0.1%next day +0.6% · 5 days −0.5% | ↗ |
| Sep 9on TipRanks 06:50 | RPRXRoyalty Pharma · $32.7B | Reiterated | Buy | $70.00 | +14.8% | +0.5%next day −2.4% · 5 days −2.4% | ↗ |
| Sep 1on TipRanks 06:50 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,600 | +27.3% | +1.0%next day −0.4% · 5 days −3.2% | ↗ |
| Aug 31on TipRanks 07:30 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $125 | +42.5% | −0.2%next day +1.0% · 5 days −2.8% | ↗ |
| Aug 19on TipRanks Aug 18 10:17 | AMLXIWMAmylyx Pharmaceuticals Inc · $3.4B | Reiterated | Buy | $26.00 → $32.00+23.1% | +21.5% | +64.5%next day +9.7% · 5 days +6.9% | ↗ |
| Aug 14on TipRanks 06:55 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Hold | $70.00 | +17.2% | −1.1%next day +1.7% · 5 days +6.4% | ↗ |
| Aug 6on TipRanks 06:05 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $120 → $135+12.5% | +28.8% | +1.0%next day +0.4% · 5 days +6.3% | ↗ |
| Aug 5on TipRanks 06:40 | PFESPYPfizer · $168B | Reiterated | Hold | — | — | +1.8%next day +1.7% · 5 days +1.6% | ↗ |
| Aug 4on TipRanks 07:45 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Buy | $165 | +5.6% | +1.3%next day −2.4% · 5 days +0.5% | ↗ |
| Aug 3on TipRanks 06:45 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | $200 → $215+7.5% | −7.6% | −2.0%next day +1.5% · 5 days +0.6% | ↗ |
| Jul 29on TipRanks 06:38 | KNSAIWMKiniksa Pharmaceuticals · $6.2B | Reiterated | Buy | $60.00 → $100+66.7% | +27.2% | +3.4%next day −5.0% · 5 days −9.0% | ↗ |
| Jul 16on TipRanks Jul 17 05:55 | FTHFaeth Therapeutics · $517M | Reiterated | Buy | $55.00 | +192.6% | −17.0%next day +0.7% · 5 days +8.7% | ↗ |
| May 7on TipRanks May 10 09:35 | NVAXIWMNovavax · $2.1B | Reiterated | Sell | $7.00 | −37.8% | −1.1%next day +8.7% · 5 days −1.0% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗